• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers

    3/13/25 1:00:00 AM ET
    $HIMS
    $RKLB
    Medical/Nursing Services
    Health Care
    Military/Government/Technical
    Industrials
    Get the next $HIMS alert in real time by email

    MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs introduces RKLX and HIMZ, two 2X leveraged single-stock ETFs designed to provide amplified exposure to Rocket Lab USA, Inc. (NASDAQ:RKLB) and Hims & Hers Health Inc. (NYSE:HIMS). These ETFs offer traders a way to seek enhanced returns on Rocket Lab and Hims & Hers without requiring a margin account.

    • RKLX, the Defiance Daily Target 2X Long RKLB ETF, seeks daily investment results that correspond to twice (200%) the daily percentage change of Rocket Lab, a company at the forefront of satellite launches, space exploration, and advanced aerospace systems.
    • HIMZ, the Defiance Daily Target 2X Long HIMS ETF, seeks daily investment results that correspond to twice (200%) the daily return of Hims & Hers, a company pioneering telehealth and direct-to-consumer healthcare solutions.

    "RKLX and HIMZ offer compelling opportunities for investors seeking amplified exposure to Rocket Lab and Hims & Hers, two companies driving innovation in their respective industries," said Sylvia Jablonski, CEO of Defiance ETFs. "With increasing demand for satellite technology and digital healthcare solutions, Rocket Lab and Hims & Hers continue to play key roles in shaping the future of space exploration and telehealth."

    For more information, visit DefianceETFs.com

    These Funds are not intended to be used by, and are not appropriate for, investors who do not intend to actively monitor and manage their portfolios. The Funds pursue a daily leveraged investment objective, making them riskier than alternatives that do not use leverage, as they magnify the performance of their respective underlying securities. These Funds are not suitable for all investors. They are designed for knowledgeable investors who understand the potential consequences of seeking daily leveraged (2X) investment results, recognize the risks associated with the use of leverage, and are willing to frequently monitor their portfolios. Over periods longer than a single day, the Funds may lose value even if their underlying securities increase in performance, and they will lose value if the underlying securities remain flat. An investor could lose the full principal value of their investment within a single day.

    An investment in RKLX is not an investment in Rocket Lab USA, Inc. An investment in HIMZ is not an investment in Hims & Hers Health Inc.

    About Defiance ETFs

    Founded in 2018, Defiance is at the forefront of ETF innovation. Defiance is a leading ETF issuer specializing in thematic, income, and leveraged ETFs.

    Our first-mover leveraged single-stock ETFs empower investors to take amplified positions in high-growth companies, providing precise leverage exposure without the need to open a margin account.

    IMPORTANT DISCLOSURES

    Defiance ETFs LLC is the ETF sponsor. The Fund's investment adviser is Tidal Investments, LLC ("Tidal" or the "Adviser").

    The Funds' investment objectives, risks, charges, and expenses must be considered carefully before investing. The prospectus and summary prospectus contain this and other important information about the investment company. Please read carefully before investing. A hard copy of the prospectuses can be requested by calling 833.333.9383.

    Investing involves risk. Principal loss is possible. As an ETF, the funds' may trade at a premium or discount to NAV. Shares of any ETF are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. A portfolio concentrated in a single industry or country, may be subject to a higher degree of risk.

    RKLB and HIMS Risks: The Fund invests in swap contracts and options that are based on the share price of HIMS. This subjects the Fund to certain of the same risks as if it owned shares of HIMS even though it does not.

    Indirect Investment Risk. RKLB and HIMS are not affiliated with the Trust, the Fund, or the Adviser, or their respective affiliates and are not involved with this offering in any way and have no obligation to consider your Shares in taking any corporate actions that might affect the value of Shares.

    Trading Risk. The trading price of the fund may be subject to volatility and could experience wide fluctuations due to various factors. Short sellers may also play a significant role in trading RKLB and HIMS potentially affecting the supply and demand dynamics and contributing to market price volatility. Public perception and external factors beyond the company's control may influence RKLB's and HIMS's stock price disproportionately.

    Performance Risk. RKLB and HIMS may fail to meet publicly announced guidelines or other expectations about its business, which could cause the price of RKLB and HIMS to decline.

    RKLB Aerospace & Defense Industry Risks. Companies in the aerospace and defense industry are subject to risks stemming from their reliance on government budgets and spending priorities, which can fluctuate due to political and economic pressures. The aerospace and defense industry is also affected by geopolitical tensions, trade policies, and regulatory changes that can impact market access and operational efficiency. Aerospace and defense companies typically rely on complex supply chains for specialized components and materials. Additionally, technological advancements are critical for maintaining competitiveness in this sector, but the high cost and uncertain outcomes of research and development efforts may pose financial risks. Companies in this industry face heightened cybersecurity risks due to the sensitive nature of their technologies, and breaches can lead to operational disruptions, reputational damage, and regulatory scrutiny. 

    RKLB Business Risks. RKLB has experienced rapid growth, with its employee base and operations expanding substantially in recent years, placing considerable demands on its management, operational infrastructure, and financial resources. Continued growth is dependent on RKLB's ability to scale its revenue, improve operational efficiencies, and maintain profitability while effectively managing its increasingly complex organizational structure. Additionally, interruptions from information technology failures, cybersecurity breaches, or other infrastructure issues could disrupt operations. RKLB's ability to comply with applicable regulations and adapt to changes in the industry also presents ongoing risks.

    HIMS Healthcare Providers & Services Industry Risks. The healthcare providers and services industry can be significantly affected by changing economic conditions, evolving patient demographics, and fluctuations in demand for healthcare services. Changes in healthcare regulations and policies, including those related to insurance coverage and reimbursement, can materially impact the industry. Additionally, the industry faces risks related to litigation, operational disruptions, and evolving technologies that may alter traditional service delivery models.

    HIMS Business Risks. HIMS operates in highly competitive markets, facing challenges from established healthcare providers, retailers, pharmaceutical companies, and technology firms, which may affect its competitive position. Additionally, the success of HIMS is heavily reliant on its brand reputation, relationships with healthcare providers and medical groups, and compliance with complex healthcare and pharmacy regulations. Security breaches, data loss, legal proceedings, or regulatory changes could harm its operations and reputation.

    RKLX and HIMZ Fund Risks 

    Leverage Risk. The Fund obtains investment exposure in excess of its net assets by utilizing leverage and may lose more money in market conditions that are adverse to its investment objective than a fund that does not utilize leverage. An investment in the Fund is exposed to the risk that a decline in the daily performance of the Underlying Security will be magnified.

    High Portfolio Turnover Risk. Daily rebalancing of the Fund's holdings pursuant to its daily investment objective causes a much greater number of portfolio transactions when compared to most ETFs.

    Liquidity Risk. Some securities held by the Fund may be difficult to sell or be illiquid, particularly during times of market turmoil. Markets for securities or financial instruments could be disrupted by a number of events, including, but not limited to, an economic crisis, natural disasters, epidemics/pandemics, new legislation or regulatory changes inside or outside the United States.

    Derivatives Risk. The Fund's investments in derivatives may pose risks in addition to, and greater than, those associated with directly investing in securities or other ordinary investments, including risk related to the market, leverage, imperfect daily correlations with underlying investments or the Fund's other portfolio holdings, higher price volatility, lack of availability, counterparty risk, liquidity, valuation and legal restrictions.

    Compounding and Market Volatility Risk. The Fund has a daily leveraged investment objective and the Fund's performance for periods greater than a trading day will be the result of each day's returns compounded over the period, which is very likely to differ from two times (200%) the Underlying Security's performance, before the Fund's management fee and other expenses.

    Fixed Income Securities Risk. When the Fund invests in fixed income securities, the value of your investment in the Fund will fluctuate with changes in interest rates. Typically, a rise in interest rates causes a decline in the value of fixed income securities owned by the Fund.

    Single Issuer Risk. Issuer-specific attributes may cause an investment in the Fund to be more volatile than a traditional pooled investment which diversifies risk of the market generally. The value of the Fund, which focuses on an individual security, may be more volatile than a traditional pooled investment or the market as a whole and may perform differently from the value of a traditional pooled investment or the market as a whole.

    New Fund Risk. The Fund is a recently organized management investment company with no operating history. As a result, prospective investors do not have a track record or history on which to base their investment decisions.

    Diversification does not ensure a profit nor protect against loss in a declining market.

    Brokerage Commissions may be charged on trades.

    Distributed by Foreside Fund Services, LLC

    Contact Information

    David Hanono

    [email protected]

    833.333.9383

    A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/25cf1c68-b060-42fa-b3cf-e1315eea5f0e



    Get the next $HIMS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HIMS
    $RKLB

    CompanyDatePrice TargetRatingAnalyst
    Rocket Lab Corporation
    $RKLB
    11/12/2025$55.00 → $63.00Buy
    Needham
    Hims & Hers Health Inc.
    $HIMS
    10/21/2025Sector Weight
    KeyBanc Capital Markets
    Rocket Lab Corporation
    $RKLB
    10/16/2025$83.00Outperform
    Robert W. Baird
    Rocket Lab Corporation
    $RKLB
    7/28/2025$51.00Hold
    Craig Hallum
    Rocket Lab Corporation
    $RKLB
    6/30/2025$27.00Neutral
    Goldman
    Hims & Hers Health Inc.
    $HIMS
    6/23/2025Buy → Hold
    Needham
    Hims & Hers Health Inc.
    $HIMS
    6/4/2025$61.00 → $65.00Buy
    Needham
    Hims & Hers Health Inc.
    $HIMS
    4/29/2025$30.00Buy → Hold
    TD Cowen
    More analyst ratings

    $HIMS
    $RKLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Boughton Soleil sold $112,152 worth of shares (2,637 units at $42.53), decreasing direct ownership by 2% to 155,856 units (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    11/12/25 8:02:48 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Dudum Andrew gifted 3,266,494 shares, received a gift of 3,266,494 shares and disposed of 260,000 shares (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    11/12/25 8:02:42 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Chief Legal Officer Boughton Soleil sold $132,114 worth of shares (2,637 units at $50.10), decreasing direct ownership by 2% to 158,493 units (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    10/28/25 4:23:37 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RKLB
    Leadership Updates

    Live Leadership Updates

    View All

    Niron Magnetics Expands Board of Directors with Seasoned Technology and Finance Experts to Lead the Next Chapter of Growth

    Jon Olson, current Board Member at AMD, Rocket Lab, and Kulicke & Soffa, and Eric Stang, CEO and Chairman of Ooma and current Board Member of Rambus, join Niron Magnetics' Board of Directors Niron Magnetics, the company manufacturing high-performance Iron Nitride permanent magnets made without rare earths, announced the appointment of Jon Olson and Eric Stang to its Board of Directors. Their deep experience in technology, finance, and scaling high-growth public and private companies will help guide Niron Magnetics' journey as it expands manufacturing, commercial operations, and global partnerships in preparation for future growth. "Niron Magnetics is entering a pivotal moment. We're sca

    11/12/25 10:00:00 AM ET
    $AMD
    $KLIC
    $OOMA
    Semiconductors
    Technology
    EDP Services
    Military/Government/Technical

    Rocket Lab Schedules Fifth Electron Mission for Constellation Operator iQPS

    Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced the launch window for its next mission for multi-launch customer, Institute for Q-shu Pioneers of Space, Inc. (iQPS), a Japan-based Earth imaging company – marking Electron's 69th mission to date and 11th launch this year. The mission, named ‘The Harvest Goddess Thrives', is scheduled to launch from Rocket Lab Launch Complex 1 in New Zealand during a launch window that opens on August 5, 2025 UTC. The mission will deploy QPS-SAR-12, nicknamed KUSHINADA-I for the Japanese goddess of harvest and prosperity, to a 575km circular Earth orbit to join the re

    7/31/25 4:15:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer

    Mo Elshenawy joins as the company doubles down on the role AI will play in the next generation of healthcare. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the appointment of Mo Elshenawy, a proven technology executive with deep expertise in artificial intelligence and large-scale infrastructure, as the company's new Chief Technology Officer. His appointment marks a key milestone as Hims & Hers accelerates its vision to build the next-generation healthcare platform, powered by AI and designed to deliver deeply personalized, accessible care at scale. This press release features multimedia. View the full release here: https://www.businesswire

    5/8/25 6:50:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RKLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham reiterated coverage on Rocket Lab USA with a new price target

    Needham reiterated coverage of Rocket Lab USA with a rating of Buy and set a new price target of $63.00 from $55.00 previously

    11/12/25 8:03:22 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    KeyBanc Capital Markets initiated coverage on Hims & Hers Health

    KeyBanc Capital Markets initiated coverage of Hims & Hers Health with a rating of Sector Weight

    10/21/25 7:20:02 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Robert W. Baird initiated coverage on Rocket Lab USA with a new price target

    Robert W. Baird initiated coverage of Rocket Lab USA with a rating of Outperform and set a new price target of $83.00

    10/16/25 8:28:24 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $HIMS
    $RKLB
    SEC Filings

    View All

    SEC Form 10-Q filed by Rocket Lab Corporation

    10-Q - Rocket Lab Corp (0001819994) (Filer)

    11/10/25 4:26:20 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Rocket Lab Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - Rocket Lab Corp (0001819994) (Filer)

    11/10/25 4:18:08 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    SEC Form 10-Q filed by Hims & Hers Health Inc.

    10-Q - Hims & Hers Health, Inc. (0001773751) (Filer)

    11/3/25 4:16:56 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RKLB
    Financials

    Live finance-specific insights

    View All

    Rocket Lab Announces Third Quarter 2025 Financial Results, Posts Record Quarterly Revenue of $155m, Representing 48% Year-on-Year Growth at Record Gross Margin

    LONG BEACH, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab", "the Company", "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal third quarter ended September 30, 2025. Rocket Lab founder and CEO, Sir Peter Beck, said: "This past quarter we've once again delivered record revenue of $155m at record GAAP gross margin of 37%, and a new annual launch record is just days away. With progress across our major space systems programs, record backlog of contracts for our launch services business, and well-timed, strategic M&A in growth areas that are well-aligned with next-generation d

    11/10/25 4:15:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial Results

    Revenue of nearly $600 million, up 49% year-over-year in Q3 2025 Net income of nearly $16 million; Adjusted EBITDA of over $78 million in Q3 2025 Subscribers grew to almost 2.5 million, up 21% year-over-year in Q3 2025 Narrows full year 2025 revenue guidance to $2.335 billion to $2.355 billion and Adjusted EBITDA guidance to $307 million to $317 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a shareholder letter that is posted at investors.hims.com. "This quarter we continued to prove that our vision of helping tens of mill

    11/3/25 4:05:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Rocket Lab Announces Date of Third Quarter 2025 Financial Results

    LONG BEACH, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that it will release its financial results for the third quarter 2025 following the close of the U.S. markets on Monday November 10, 2025. Rocket Lab will host a corresponding conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live webcast and replay of the conference call will be available on the Company's Investor Relations website at www.investors.rocketlabcorp.com. Rocket Lab Investor Relations Contact Patrick [email protected] Rocket Lab Media Contact Mur

    10/22/25 4:30:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $HIMS
    $RKLB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rocket Lab-Built Twin Spacecraft Begin Mars Journey for NASA and UC Berkeley's ESCAPADE Mission

    LONG BEACH, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a leading launch and space systems company, today announced its two Explorer-class spacecraft for NASA and the University of California Berkeley's Space Sciences Laboratory have been successfully launched, beginning their journey to Mars to study the Red Planet's magnetosphere. NASA's Escape and Plasma Acceleration and Dynamics Explorers (ESCAPADE) mission was launched by Blue Origin on November 13, from Cape Canaveral Space Force Station at 03:55 p.m. EST. Rocket Lab has successfully established contact with the spacecraft and they are generating power. Now in orbit

    11/13/25 11:57:44 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Hims & Hers Introduces Labs, a Holistic, In-Depth Testing Experience That Puts Customers in Control of Their Health and Wellness Journeys

    With Labs, Hims & Hers is creating an accessible, affordable, data-driven future for healthcare Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced the launch of Labs, a new way for customers to understand their overall health and identify ways to improve and maintain it. Labs measures key markers over time and provides doctor-developed action plans that can power real shifts in health outcomes. With this new, proactive experience, Hims & Hers is making it accessible, affordable, and simple for customers to get and stay healthy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2025111324

    11/13/25 12:00:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Niron Magnetics Expands Board of Directors with Seasoned Technology and Finance Experts to Lead the Next Chapter of Growth

    Jon Olson, current Board Member at AMD, Rocket Lab, and Kulicke & Soffa, and Eric Stang, CEO and Chairman of Ooma and current Board Member of Rambus, join Niron Magnetics' Board of Directors Niron Magnetics, the company manufacturing high-performance Iron Nitride permanent magnets made without rare earths, announced the appointment of Jon Olson and Eric Stang to its Board of Directors. Their deep experience in technology, finance, and scaling high-growth public and private companies will help guide Niron Magnetics' journey as it expands manufacturing, commercial operations, and global partnerships in preparation for future growth. "Niron Magnetics is entering a pivotal moment. We're sca

    11/12/25 10:00:00 AM ET
    $AMD
    $KLIC
    $OOMA
    Semiconductors
    Technology
    EDP Services
    Military/Government/Technical

    $HIMS
    $RKLB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Manuel Anja bought $132,260 worth of shares (5,000 units at $26.45) (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    11/14/24 4:57:45 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Payne Christopher D bought $1,951,763 worth of shares (110,000 units at $17.74) (SEC Form 4)

    4 - Hims & Hers Health, Inc. (0001773751) (Issuer)

    5/22/24 4:16:26 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $HIMS
    $RKLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/5/24 9:49:25 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/3/24 9:39:57 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13G/A filed by Rocket Lab USA Inc.

    SC 13G/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    11/12/24 4:45:55 PM ET
    $RKLB
    Military/Government/Technical
    Industrials